Supplements vergleichen

VAGINAL USE ONLY, by applicator: 2 x 10^9 CFU per dose. The phase 2b regimen was one dose daily for 5 days in week 1, then twice weekly for a further 10 weeks — always started after a completed course of vaginal metronidazole gel.

Any time

Vaginal applicator delivering L. crispatus CTV-05

Prescription-only, clinician-titrated. Subcutaneous (Wegovy weight management: escalate to 2.4 mg once weekly; Ozempic diabetes: 0.5-2.0 mg once weekly). Oral (Rybelsus diabetes: 3-14 mg once daily). DO NOT self-dose.

Any time

Subkutane einmal wöchentliche Injektion (Ozempic / Wegovy)

• Not established for anyone outside the trial populations — otherwise-healthy non-pregnant women aged 14-45
• Immunocompromise or immunosuppressive therapy (chemotherapy, transplant medication, high-dose corticosteroids, advanced HIV) — a live organism that no trial has studied in this population; use only under clinician supervision
• Critical illness, an indwelling central venous catheter, or a disrupted mucosal barrier — no vaginal-lactobacillus infection has been reported, but oral probiotics have caused documented bloodstream infection in these settings

• Vaginal metronidazole gel

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Prior serious hypersensitivity to semaglutide or any GLP-1 receptor agonist

• Insulin and sulfonylureas
• Oral medications (general)
• Other GLP-1 receptor agonists